Brenda Z (Fuzapladib Sodium) – Injectable for Acute Canine Pancreatitis Management

Give your patients faster recovery from the painful and potentially life-threatening inflammation of acute canine pancreatitis with Brenda Z (fuzapladib sodium for injection), the innovative leukocyte function-associated antigen-1 (LFA-1) activation inhibitor.

First introduced in Japan (as ブリンダZ) and now recognized globally (equivalent to Panoquell-CA1 in other markets), Brenda Z specifically blocks neutrophil migration and the hallmark neutrophilic inflammation in the pancreas - helping to manage clinical signs during the critical acute phase.